1.	CUP Project PET/CT Phase: Phase IV Type: Diagnostic Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: K36, NCT01469026
2.	Phase III Randomized Study of Two Different Dose Schedules of Paclitaxel in Combination With Carboplatin With Versus Without Concurrent and Consolidation Bevacizumab in Patients With Stage II-IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer and ACRIN 6695: Study of Perfusion CT Imaging to Evaluate Treatment Response in These Patients (Patients enrolled after 02/08/2012 must participate in the ACRIN 6695 component and the study is no longer randomized) Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0262, GOG-0262, NCT01167712
3.	Study of Multiphase Contrast-Enhanced CT Scan and Multiphase Contrast-Enhanced MRI for Diagnosing and Staging Hepatocellular Carcinoma in Patients With Chronic Liver Disease Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: ACRIN-6690, ACRIN-6690, NCT01082224
4.	Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma Phase: No phase specified Type: Diagnostic Status: Approved-not yet active Age: 35 and over Sponsor: Other Protocol IDs: 231-06, NCT00587132